Establishment and Development of National Community-Based Collaborative Innovation Demonstration Areas to Achieve the Control Target of Hepatitis B in China
Bing Ruan,Zhixin Yu,Shigui Yang,Kaijin Xu,Jingjing Ren,Jun Yao,Nanping Wu,Chengbo Yu,Min Deng,Tiansheng Xie,Ping Chen,Chencheng Wang,Yiping Li,Yanhong Zhao,Jifang Sheng,Yunde Hou,Zunyou Wu,Shuigao Jin,Yude Chen,Mengfeng Li,Fengcai Zhu,Hong Tang,Yuantao Hao,Xinghuo Pang,Lin Lu,Wen Yang,Zhengan Yuan,Aiqiang Xu,Zizhao Li,Mingjian Ni,Yongping Yan,Qiu Zhong,Lin Zhou,Guojian Li,Qun Meng,Jianping Hu,Hong Zhou,Guangyu Zhang,Dexin Li,Wei Jiang,Qing Li,Peixin Wu,Ruoqi Xing,Jinhui Gu,Di Gao,Lanjuan Li
DOI: https://doi.org/10.1186/s12879-019-4150-9
IF: 3.7
2019-01-01
BMC Infectious Diseases
Abstract:BACKGROUND:The major infectious diseases of hepatitis B has constituted an acute public health challenge in China. An effective and affordable HBV control model is urgently needed. A national project of Community-based Collaborative Innovation HBV (CCI-HBV) demonstration areas has optimized the existing community healthcare resources and obtained initial results in HBV control.METHODS:Based on the existing community healthcare network, CCI-HBV project combined the community health management and health contract signing service for long-staying residents in hepatitis B screening. Moreover, HBV field research strategy was popularized in CCI-HBV areas. After screening, patients with seropositive results were enrolled in corresponding cohorts and received treatment at an early stage. And the uninfected people received medical supports including health education through new media, behavior intervention and HBV vaccinations. In this process, a cloud-based National Information Platform (NIP) was established to collect and store residents' epidemiological data. In addition, a special quality control team was set up for CCI project.RESULTS:After two rounds of screening, HBsAg positive rate dropped from 5.05% (with 5,173,003 people screened) to 4.57% (with 3,819,675 people screened), while the rate of new HBV infections was 0.28 per 100 person-years in the fixed cohorts of 2,584,322 people. The quality control team completed PPS sampling simultaneously and established the serum sample database with 2,800,000 serum samples for unified testing.CONCLUSIONS:CCI-HBV project has established a large-scale field research to conduct whole-population screening and intervention. We analyzed the HBsAg prevalence and new infection rate of HBV in the fixed population for the epidemic trend and intervention effect. The purpose of CCI-HBV project is to establish and evaluate a practical model of grid management and field strategy, to realize the new goal to control hepatitis B in China. To provide policymakers with a feasible model, our results are directly applicable.TRIAL REGISTRATION:The project was funded by the Major Projects of Science Research for the 11th and 12th five-year plans of China, entitled "The prevention and control of AIDS, viral hepatitis and other major infectious diseases", Grant Nos. 2009ZX10004901, 2011ZX10004901, 2013ZX10004904, 2014ZX10004007 and 2014ZX10004008.